• Approximately 259.8 million options exercised, delivering $7.8m funds
• Funds used to repay outstanding debt, reducing debt to ~$9.7m
• Atomos increasingly confident of delivering H1'26 sales of $23m - $25m and H1'26 EBITDA of $1.5m - $2.0m

Atomos Limited (ASX:AMS), a global leader in innovative video technology products and solutions, has provided an update on the exercise and expiry of its ASX-listed options (ASX:AMSO). Approximately 259.8 million ASX-listed options were exercised, delivering $7.8m in funds into the business. These funds will be used to repay a portion of the $17.5m of outstanding debt (which includes capitalised interest to 30 November 2025), resulting in approximately ~$9.7m of outstanding debt in the business. All other terms of the Monreii Facility (as announced on 2 April 2025) remain the same, with an interest rate of 16%, a 4% line fee, capitalising interest and a maturity of 28 February 2027. Atomos is increasingly confident of delivering H1'26 sales of $23m - $25m and H1'26 EBITDA in the range of $1.5m - $2.0m, following strong November trading. The company's Managing Director and CEO, Peter Barber, commented that reducing the debt balance is a key corporate initiative on the journey to rebuilding the Atomos brand and returning value to shareholders.

Atomos is increasingly confident of delivering H1'26 sales of $23m - $25m and H1'26 EBITDA in the range of $1.5m - $2.0m.